If a plateau occurs, your PlexusDx provider reviews your metabolic markers, genetic test results, and response pattern to determine whether increasing the current medication's dose or switching to a dual-compound option (such as GLP-Squared) is more appropriate
For researchers currently on semaglutide who feel they have room for more weight loss, either CagriSema or tirzepatide represents a meaningful upgrade
This information should be interpreted with a qualified healthcare provider alongside clinical biomarkers to support a more personalized treatment conversation
The GLP-1 trend appears to present three distinct investment opportunities
We will discuss this part in the following section
In my practice, some patients have reported temporary worsening of fatigue, pain, dizziness, or neurologic symptoms following COVID-19 vaccination